Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Acasti Pharma Inc
ACST
Healthcare
Acasti Pharma Inc. is a Canada-based late-stage biopharma company with drug candidates addressing rare and orphan diseases. The Company is targeting three underserved orphan diseases: GTX-104, an intravenous infusion targeting subarachnoid hemorrhage (SAH), a rare and life-threatening medical emergency, in which bleeding occurs over the surface of the brain in the subarachnoid space between the...
brain and skull; GTX-102, an oral mucosal spray targeting ataxia-telangiectasia (A-T), a progressive, neurodegenerative genetic disease that primarily impacts children causing severe disability; and GTX-101, a topical spray, targeting postherpetic neuralgia, a persistent and often debilitating neuropathic pain caused by nerve damage from the varicella zoster virus (shingles). The Company’s clinical assets have each been granted Orphan Drug Designation by the FDA, which provides seven years of marketing exclusivity post-launch in the United States, and additional intellectual property protection.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:ACST)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(1848)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Jun 30, 2020 9:51am
RE:Oppenheimer still rates this a Buy
$7.00 US. target..... Oppenheimer Thinks Acasti Pharma’s Stock is Going to Recover Ryan Adist- June 30, 2020, 7:17 AM EDT SHARE ON: In a
...more
(77)
•••
Rosmorduc
X
View Profile
View Bullboard History
Post by
Rosmorduc
on Jun 30, 2020 9:44am
With COVID-19 first wave ongoing & second wave coming
I believe CAPRE as a therapeutic can be more important and impactful than any phony vaccine. Firstly, there are no vaccines for Corona viruses like the common cold. A vaccine is a shot in the
...more
Silvercorp to Acquire Adventus, Creating a Diversified Mining Company
posted May 02, 2024 9:00am by
Adventus Mining Corp.
-
|
Under the terms of the Arrangement Agreement, each holder of the common shares of Adventus will receive 0.1015 of one Silvercorp common share in exchange for each Adventus Share at the effective time of the Transaction. The Exchange Ratio implies consideration of C$0.50 per Adventus Share ...read more
(77)
•••
Rosmorduc
X
View Profile
View Bullboard History
Comment by
Rosmorduc
on Jun 30, 2020 8:15am
RE:Oppenheimer still rates this a Buy
Well, Jan stated clearly that based on the data and deep intel they have, Trilogy 2 will be sufficient to push CAPRE to approval. As I said yesterday, see this as a gift and load up more here. CAPRE
...more
(51)
•••
Canadian_101
X
View Profile
View Bullboard History
Post by
Canadian_101
on Jun 30, 2020 8:11am
Oppenheimer still rates this a Buy
Well looks like they saw or heard something I did not or simply are hoping the next set of trial results are going to be a lot better!!! Will continue to hold a core position till T2 results
...more
(77)
•••
Rosmorduc
X
View Profile
View Bullboard History
Comment by
Rosmorduc
on Jun 30, 2020 8:10am
RE:RE:RE:RE:T2 FDA Discussions
Yes, the screw up happened before the ball game even began. They had a bunch of patients who were already on diet and exercise and magically cornstarch placebo had overwhelming effects!!! So FDA
...more
(44)
•••
postie1
X
View Profile
View Bullboard History
Comment by
postie1
on Jun 30, 2020 4:44am
RE:RE:RE:T2 FDA Discussions
Isn't the screw up before the trial even started. Is it possible that the FDA is saying you can't change requirements but a lot of people did not fit the requirements to begin with? I am
...more
(72)
•••
TechOne
X
View Profile
View Bullboard History
Post by
TechOne
on Jun 30, 2020 2:04am
Acasti Pharma Earnings Call Transcript
https://seekingalpha.com/article/4356274-acasti-pharma-inc-acst-ceo-jan-dalvise-on-q4-2020-results-earnings-call-transcript?utm_medium=email&utm_source=seeking_alpha&mail_subject=acst-acasti
...more
(1848)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on Jun 29, 2020 11:00pm
Trilogy 2 vs Trilogy 1
Finally, I'm sure you're wondering what the odds are that TRILOGY 2 will be affected by the same pre-randomization triglyceride normalization effect that we saw in TRILOGY 1. It's honestly
...more
(77)
•••
Rosmorduc
X
View Profile
View Bullboard History
Comment by
Rosmorduc
on Jun 29, 2020 10:28pm
RE:Transcript
From the transcript, Jan states: "We're carefully considering the FDA's comments on the Trilogy 1 data, and we will continue to conduct further post-hoc analysis based on their feedback.
...more
(1848)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on Jun 29, 2020 10:12pm
Transcript
https://seekingalpha.com/article/4356274-acasti-pharma-inc-acst-ceo-jan-dalvise-on-q4-2020-results-earnings-call-transcript?part=single
(13)
•••
Danny1082Man
X
View Profile
View Bullboard History
Comment by
Danny1082Man
on Jun 29, 2020 9:59pm
RE:RE:T2 FDA Discussions
I'm thinking yes the SAP for T2 stays the same with the ITT population, but maybe since so many got washed out under 500 TG they no longer fit the ITT requirement between 500 and 1500. The ITT was
...more
(77)
•••
Rosmorduc
X
View Profile
View Bullboard History
Comment by
Rosmorduc
on Jun 29, 2020 9:00pm
RE:My e-mail to Pierre, cc Jan
Francine, all you need to ask them simply is why they didn't copy the Vascepa phase 3 trial scope? This intelligence was public/available and all they had to do is copy and paste that and CAPRE
...more
(3)
•••
boozehound3
X
View Profile
View Bullboard History
Comment by
boozehound3
on Jun 29, 2020 7:57pm
RE:My e-mail to Pierre, cc Jan
Here is Pierre"s cell number. 514 824 9902. Give him a shout !
(52)
•••
Francine01
X
View Profile
View Bullboard History
Post by
Francine01
on Jun 29, 2020 7:41pm
My e-mail to Pierre, cc Jan
Salut Pierre, After the 1PM conf call, I was kind of pi**ed off the answers provided by you and Janelle. I have a lost in the 6 digits ($) so I went for a walk around the Olympic Stadium
...more
(18)
•••
EternalPonzi
X
View Profile
View Bullboard History
Comment by
EternalPonzi
on Jun 29, 2020 6:29pm
RE:Incorrect design trial
Yep. Good luck getting rid of them. They have a nice Iittle racket going and will fight tooth and nail to maintain their positions until the money runs out. They have gifted
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Mullen Group Ltd. Reports 2024 First Quarter Financial Results
Significant New Silver Discoveries in the Famous Keno Hill District in the Yukon
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition
Silvercorp to Acquire Adventus, Creating a Geographically Diversified Mining Company
Revolutionary Tech Company Announces Fourth Quarter and Full Year 2023 Results
Drill Permit Approval Received for New Mexico Lithium Project
This profitable gold stock is on its way up